Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 History and current impact of cardiac magnetic resonance imaging on the management of iron overload.

Literature DB >> 19884464

History and current impact of cardiac magnetic resonance imaging on the management of iron overload.

John C Wood.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：
Ferritins
Iron

Year: 2009 PMID： 19884464 PMCID： PMC2884388 DOI： 10.1161/CIRCULATIONAHA.109.907196

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

20 in total

1. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.

Authors: L J Anderson; S Holden; B Davis; E Prescott; C C Charrier; N H Bunce; D N Firmin; B Wonke; J Porter; J M Walker; D J Pennell
Journal: Eur Heart J Date: 2001-12 Impact factor: 29.983

2. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.

Authors: Lisa J Anderson; Beatrix Wonke; Emma Prescott; Sally Holden; J Malcolm Walker; Dudley J Pennell
Journal: Lancet Date: 2002-08-17 Impact factor: 79.321

3. Iron in the heart. Etiology and clinical significance.

Authors: L M Buja; W C Roberts
Journal: Am J Med Date: 1971-08 Impact factor: 4.965

Review 4. Iron overload: causes and consequences.

Authors: V R Gordeuk; B R Bacon; G M Brittenham
Journal: Annu Rev Nutr Date: 1987 Impact factor: 11.848

5. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register.

Authors: B Modell; M Khan; M Darlison
Journal: Lancet Date: 2000-06-10 Impact factor: 79.321

6. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.

Authors: Lisa J Anderson; Mark A Westwood; Sally Holden; Bernard Davis; Emma Prescott; Beatrix Wonke; John B Porter; J Malcolm Walker; Dudley J Pennell
Journal: Br J Haematol Date: 2004-11 Impact factor: 6.998

7. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major.

Authors: Bernard A Davis; Caoimhe O'Sullivan; Peter H Jarritt; John B Porter
Journal: Blood Date: 2004-03-04 Impact factor: 22.113

8. Mimicking liver iron overload using liposomal ferritin preparations.

Authors: John C Wood; Joe D Fassler; Tom Meade
Journal: Magn Reson Med Date: 2004-03 Impact factor: 4.668

9. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors: Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal: J Magn Reson Imaging Date: 2003-07 Impact factor: 4.813

10. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.

Authors: P Kirk; M Roughton; J B Porter; J M Walker; M A Tanner; J Patel; D Wu; J Taylor; M A Westwood; L J Anderson; D J Pennell
Journal: Circulation Date: 2009-10-02 Impact factor: 29.690

19 in total

1. Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice?

Authors: Agustin Castiella; Jose M Alústiza; Jose I Emparanza; Eva Ma Zapata; Belen Costero; Maria I Díez
Journal: Eur Radiol Date: 2010-08-06 Impact factor: 5.315

2. Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate.

Authors: Daniel Kim; Jens H Jensen; Ed X Wu; Li Feng; Wing-Yan Au; Jerry S Cheung; Shau-Yin Ha; Sujit S Sheth; Gary M Brittenham
Journal: NMR Biomed Date: 2010-12-28 Impact factor: 4.044

Review 3. Use of magnetic resonance imaging to monitor iron overload.

Authors: John C Wood
Journal: Hematol Oncol Clin North Am Date: 2014-08 Impact factor: 3.722

4. Heart Rate Recovery as a Novel Test for Predicting Cardiac Involvement in Beta-Thalassemia Major.

Authors: Selcuk Kucukseymen; Isa Oner Yuksel; Goksel Cagirci; Erkan Koklu; Volkan Karakus; Serkan Cay; Gorkem Kus; Erdal Kurtoglu; Sakir Arslan
Journal: Acta Cardiol Sin Date: 2017-07 Impact factor: 2.672

5. Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia.

Authors: Jerry S Cheung; Wing-Yan Au; Shau-Yin Ha; Daniel Kim; Jens H Jensen; Iris Y Zhou; Matthew M Cheung; Yin Wu; Hua Guo; Pek-Lan Khong; Truman R Brown; Gary M Brittenham; Ed X Wu
Journal: J Magn Reson Imaging Date: 2011-06 Impact factor: 4.813

6. Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.

Authors: Luca Antonio Felice Di Odoardo; Marianna Giuditta; Elena Cassinerio; Alberto Roghi; Patrizia Pedrotti; Marco Vicenzi; Veronica Maria Sciumbata; Maria Domenica Cappellini; Alberto Pierini
Journal: Intern Emerg Med Date: 2017-04-29 Impact factor: 3.397